Skip to main content
Tiziana files IND for oral formulation of drug for NASH, liver disease
3/20/2019

An investigational new drug application was filed by Tiziana Life Sciences with the FDA for an early-stage study of enteric-coated capsules of foralumab in healthy volunteers. The drug is being assessed as a treatment for patients with nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.

Full Story: